In 1992, the CMIC Group launched the business called CRO (pharmaceutical development support)
for the first time in Japan, and has responded to various customer needs as a leading company.
Beyond the scope of CRO’s responsibilities, we were able to establish systems that provide services to all operations related to drug development.
We will utilize our extensive experience and knowledge to meet customers’
expectations, to build a business model that can create new value,
and to contribute to the development of the medical and healthcare field.